ARTIVION INC (AORT) Stock Price, Forecast & Analysis
NYSE:AORT • US2289031005
AORT Key Statistics, Chart & Performance
The current stock price of AORT is 38.06 USD. In the past month the price decreased by -5.45%. In the past year, price increased by 59.43%.
AORT Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AORT. When comparing the yearly performance of all stocks, AORT is one of the better performing stocks in the market, outperforming 80.08% of all stocks.
AORT Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AORT. AORT has only an average score on both its financial health and profitability.
AORT Financial Highlights
Over the last trailing twelve months AORT reported a non-GAAP Earnings per Share(EPS) of 0.18. The EPS increased by 141.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| Debt/Equity | 0.5 |
AORT Forecast & Estimates
13 analysts have analysed AORT and the average price target is 52.46 USD. This implies a price increase of 37.83% is expected in the next year compared to the current price of 38.06.
For the next year, analysts expect an EPS growth of 151.03% and a revenue growth 11.61% for AORT
AORT Ownership
AORT Latest News, Press Relases and Analysis
AORT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.74 | 198.44B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.93 | 176.233B | ||
| SYK | STRYKER CORP | 25.15 | 148.004B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.89 | 113.036B | ||
| IDXX | IDEXX LABORATORIES INC | 42.74 | 50.84B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.45 | 50.591B | ||
| BDX | BECTON DICKINSON AND CO | 11.04 | 50.298B | ||
| RMD | RESMED INC | 21.02 | 37.497B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.54 | 36.533B | ||
| DXCM | DEXCOM INC | 28.88 | 28.776B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AORT
Company Profile
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Company Info
ARTIVION INC
1655 Roberts Boulevard N W
Kennesaw GEORGIA US
Employees: 1600
Phone: 17704193355
ARTIVION INC / AORT FAQ
Can you describe the business of ARTIVION INC?
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
What is the stock price of ARTIVION INC today?
The current stock price of AORT is 38.06 USD. The price decreased by -1.27% in the last trading session.
What is the dividend status of ARTIVION INC?
AORT does not pay a dividend.
How is the ChartMill rating for ARTIVION INC?
AORT has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for AORT stock?
13 analysts have analysed AORT and the average price target is 52.46 USD. This implies a price increase of 37.83% is expected in the next year compared to the current price of 38.06.
Can you provide the upcoming earnings date for ARTIVION INC?
ARTIVION INC (AORT) will report earnings on 2026-05-04.